On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
All content for Personalized Medicine Podcast is the property of Oleksandr Yagensky and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
Ep#044: Applying Nanoparticles and Microfluidics to Personalized Medicine with Martin Rabel
Personalized Medicine Podcast
48 minutes
3 years ago
Ep#044: Applying Nanoparticles and Microfluidics to Personalized Medicine with Martin Rabel
Welcome to the next episode of the Personalized Medicine Podcast. In this episode, our host Aradhana talked to Martin Rabel, the Field Application Scientist at Precision Nanosystems, about nanoparticles, microfluidics, gene delivery in the context of personalized medicine.
Tune in to this episode to learn more about:
◦ Precision Nanosystems and their mission
◦ Role of nanoparticles and microfluidics in Personalized Medicine
◦ Next-Gen microfluidics technologies
◦ Application of nanoparticles in pharmaceutical applications
◦ Challenges in developing RNA-based lipid nanoparticles
◦ Role of regulatory bodies in implementation of personalized medicine approaches
◦ The outlook on the future of personalized medicine
Get in touch with Martin:
◦ LinkedIn: Martin Rabel
◦ Twitter: @rabel_martin
Personalized Medicine Podcast
On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
